Az oldal megfelelő megjelenítéséhez engedélyezze böngészőjében a JavaScript használatát!

You are here

Maroda László

Maroda László

Name: Maroda László

Publication list

printer-friendly version

Export to MTMT compatible RIS file
Upload publications
Request certified publication list

Uploaded publications:

6

Publications in DEA:

6

OA:

3

Date range:

2018-2024

2024

Kovács, B., Németh, Á., Daróczy, B., Karányi, Z., Maroda, L., Diószegi, Á., Páll, D., Harangi, M.: A lipidanyagcsere eltéréseinek vizsgálata felnőtt hypertoniás betegek esetén adatbányászati módszerrel.
Hyperton. nephrol. 28 (1), 13-18, 2024.

2023

Kovács, B., Németh, Á., Daróczy, B., Karányi, Z., Maroda, L., Diószegi, Á., Harangi, M., Páll, D.: Assessment of Hypertensive Patients' Complex Metabolic Status Using Data Mining Methods.
J. Cardiovasc. Dev. Dis. 10 (8), 1-14, 2023.

Journal metrics:

Q2 Pharmacology (medical)
Q1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Kovács, B., Németh, Á., Daróczy, B., Karányi, Z., Maroda, L., Diószegi, Á., Nádró, B., Szabó, T., Harangi, M., Páll, D.: Determining the prevalence of childhood hypertension and its concomitant metabolic abnormalities using data mining methods in the Northeastern region of Hungary.
Front. Cardiovasc. Med. 9 1-10, 2023.

Journal metrics:

Q2 Cardiology and Cardiovascular Medicine

2022

Köbling, T., Maroda, L., Katona, É., Váradi, Z., Somodi, S., Páll, D., Zrínyi, M.: Discriminating low to high adherent type 2 patients with diabetes by glycosylated hemoglobin A1c, eating self-efficacy and other psychosocial determinants: difference between patient and physician adherence models.
Patient Prefer. Adher. 16 1405-1414, 2022.

Journal metrics:

Q2 Health Policy
Q2 Medicine (miscellaneous)
Q1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Q1 Social Sciences (miscellaneous)
Kovács, B., Cseprekál, O., Diószegi, Á., Lengyel, S., Maroda, L., Paragh, G., Harangi, M., Páll, D.: The Importance of Arterial Stiffness Assessment in Patients with Familial Hypercholesterolemia.
J Clin Med. 11 (10), 1-14, 2022.

Journal metrics:

Q1 Medicine (miscellaneous)

2018

Páll, D., Maroda, L., Zrínyi, M.: A [béta]-blokkolók helye a hypertonia kezelésében, különös tekintettel a carvedilolra.
Hyperton. Nephrol. 22 (2), 89-93, 2018.

updated: 2024-12-15, 01:38